Low follistatin level is a causal risk factor for spontaneous abortion: a two-sample mendelian randomization study

Front Endocrinol (Lausanne). 2024 Jan 3:14:1255591. doi: 10.3389/fendo.2023.1255591. eCollection 2023.

Abstract

Background: Recurrent pregnancy loss is a distressing event during pregnancy, and understanding its causal factors is crucial. Follistatin, a glycoprotein involved in folliculogenesis and embryogenesis, has been implicated as a potential contributor to the risk of spontaneous abortion. However, establishing a causal relationship requires rigorous investigation using robust methods.

Methods: In this study, we utilized mendelian randomization (MR), a powerful genetic epidemiological approach, to examine the causal relationship between follistatin levels and spontaneous abortion. We obtained instrumental variables strongly associated with follistatin levels from large-scale genome-wide association from the IEU database. The inverse variance weighting (IVW) method was taken as gold standard. We also performed sensitivity test to evaluate the robustness of our result.

Results: MR analysis revealed a significant causal relationship between low follistatin levels and spontaneous abortion (p = 0.03). Sensitivity analyses, including pleiotropy test, heterogeneity test, and leave-one-out analysis, all supported the robustness of our findings.

Conclusion: Our study provides compelling evidence supporting the causal relationship between low follistatin levels and increased risk of spontaneous abortion. These findings underscore the importance of follistatin in the etiology of spontaneous abortion and suggest potential preventive interventions. Modulating follistatin levels or relevant pathways could hold promise for reducing the incidence of spontaneous abortion and improving reproductive outcomes. The utilization of MRs strengthens the validity of our results by mitigating confounding and reverse causality biases. Further research is needed to elucidate the underlying molecular mechanisms and explore therapeutic strategies targeting follistatin levels.

Keywords: abortion; follistatin; mendelian randomization; recurrent pregnancy loss; spontaneous abortion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Spontaneous* / etiology
  • Abortion, Spontaneous* / genetics
  • Female
  • Follistatin / genetics
  • Genome-Wide Association Study
  • Humans
  • Mendelian Randomization Analysis
  • Pregnancy
  • Risk Factors

Substances

  • Follistatin
  • FST protein, human

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This project was supported by the Natural Science Foundation of China (82171654) and the Clinical Medicine Plus X-Young Scholars Project of Peking University (Grant PKU2022LCXQ025.